Trademarkia Logo

Canada

C$
Trademark Search in Canada
REALIZING THE POWER OF RED

View On IC.GC.CA

REALIZING THE POWER OF RED
REGISTERED

on 9 Feb 2022

Last Applicant/ Owned by

RUBIUS THERAPEUTICS INC.

399 Binney StreetCambridge MA 02139

US

Serial Number

1993453 filed on 9th Aug 2019

Registration Number

TMA1119604 registered on 9th Feb 2022

Registration expiry Date

9th Aug 2029

Correspondent Address

BORDEN LADNER GERVAIS LLP

ATTN: INTELLECTUAL PROPERTY DEPARTMENT1000 DE LA GAUCHETIERE STREET WESTSUITE 900MONTREAL

QUEBEC

CA

H3B5H4

REALIZING THE POWER OF RED

Trademark usage description

biological cells for medical and clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory Read More

Classification Information

Class [005]
Biological cells for medical and clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, namely, metabolic enzyme deficiencies, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity, osteoporosis, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and acromegaly, genetic diseases and disorders, infectious disease, namely, blood infections, respiratory infections, topical infections, eye infections, urinary tract infections and digestive tract infections, cardiovascular diseases and disorders, and other diseases and disorders, namely, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury and seizure disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; pharmaceutical preparations of biological cells for medical and clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, namely, metabolic enzyme deficiencies, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity, osteoporosis, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and acromegaly, genetic diseases and disorders, infectious diseases, namely, blood infections, respiratory infections, topical infections, eye infections, urinary tract infections and digestive tract infections, cardiovascular diseases and disorders, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury and seizure disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders

Classification kind code

11

Class [042]
Scientific research, pharmaceutical research, medical research, technical consultation and product development for others in the field of biotechnology and development of pharmaceuticals, therapeutic agents and medical devices

Classification kind code

11

Mark Details

Serial Number

1993453

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 26th Feb 2021		Search Recorded
Submitted for opposition 20
on 26th Feb 2021		Examiner's First Report
Submitted for opposition 223
on 26th Feb 2021		Total Provisional Refusal
Submitted for opposition 48
on 11th Feb 2021		Agent Changed
Submitted for opposition 256
on 31st Aug 2020		Notification of Possible Opposition Sent
Submitted for opposition 1
on 1st Nov 2019		Created
Submitted for opposition 31
on 1st Nov 2019		Formalized
Submitted for opposition 257
on 31st Oct 2019		Designation Notification - Madrid Protocol
Submitted for opposition 228
on 9th Aug 2019		International Registration
Submitted for opposition 30
on 9th Aug 2019		Filed